-
A Silver Lining: COVID-19 Offers Independent Pharmacies a Chance to Shine
Independent pharmacies are on the front lines in the fight against COVID-19. NYS Governor Andrew Cuomo recognized their efforts in a recent press conference, stating, “The pharmacists have lines going out the door, and they’re showing up every day, day after day.” Independent pharmacies are integral in the fabric of our communities, with many treating generations of families, supporting local charities, and consistently going the extra… Read more
-
SCOTUS to Hear PCMA Case Concerning PBM Reforms
For those of you who have followed the long saga of pharmacy benefit managers (PBM) excesses, and state efforts to reign them in, may be aware that the question of the permissible scope of State regulation of PBMs has been slowly winding its way to the United States Supreme Court. After a false start last… Read more
-
Payor Insights for Manufacturers
BY: Staff Payor formulary placement and reimbursement amounts are the two most important aspects of a manufacturer’s success in the marketplace – they create pharmacy demand which in turn leads wholesale customer demand and pricing. So your product receives FDA approval – what needs to happen before your first sale? Payor Coverage Decision The very… Read more
-
Post-sale Clawbacks by PBMs
A new type of post-sale recoupment has taken the center stage: Generic Effective Rate (“GER”). This is the latest method in which PBMs continue to squeeze independent pharmacies.
Skip to content
Health Care Buzz 